Why the study?
To highlight the cardiovascular sequelae of Covid-19, particularly subclinical dysfunction of the left ventricle.
Does speckle tracking echocardiography detect subclinical left ventricular dysfunction in Covid-19 convalescent patients?
Does speckle tracking echocardiography detect subclinical left ventricular dysfunction in Covid-19 convalescent patients?
Subclinical cardiac dysfunction is common in convalescent Covid-19 patients and can be effectively detected using speckle tracking echocardiography.
Answers are grounded in this paper and cite their sources.
Subclinical LV dysfunction may be common post-COVID in young adults; leaves open need for controlled studies on screening and prognosis.
Objectives: to highlight the cardiovascular sequelae of Covid-19, especially subclinical dysfunction of the left ventricle. Materials and methods: the study included 74 Covid-19 convalescent patients with no history of cardiovascular disease, with a mean age of 42.01 years ± 1.4 years. Patients were assessed by speckle tracking echocardiography. Results: The results of our study determined that 41 (55.4%) Covid-19 convalescent patients have subclinical left ventricular systolic dysfunction, the mean GLS in the group being 15.8 ± 0.39, while in the control group no person has GLS <16% (p <0.001). Other manifestations were: diastolic dysfunction - 23 (31.1%), right ventricular dysfunction - 22 (30.1%), pericardial effusion - 19 (25.7%), symptoms - 67 (90%). Conclusions: Subclinical cardiac dysfunction is a common complication encountered in convalescent Covid-19 patients, and determination of GLS by speckle tracking echocardiography remains a practical and cost-effective tool to detect this injury; The persistence of symptoms, included in longCovid, does not correlate with the results of imaging investigations.
No takes yet. Share an insight, caveat, or question.
Sorici et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: